UNSPSC 51102822: Bacitracin/polymyxin b

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class DE109. This VA Drug Class (DE109) classifies this compound as belonging to the group ANTI-INFECTIVE, TOPICAL, OTHER.

UNSPSC 51102822 Bacitracin/polymyxin b, a Commodity code, nominally covers antibiotic ointment products, but recent state and local solicitations tagged to this code show little activity aligned with that scope. The Illinois Department of Public Health awarded a pharmaceutical warehouse contract through the MMCAP Infuse consortium for oral antibiotics (Doxycycline Hyclate and Ciprofloxacin), and Seminole County, Florida solicited Naloxone and drug deactivation systems—neither directly related to topical bacitracin/polymyxin b formulations. State and local health departments and county public health offices appear to be the primary issuing bodies under this code when activity is present, though the recent record does not support a clear pattern of repeat buyers or concentrated procurement volume.

The geographic spread is limited to Illinois and Florida based on recent opportunities. The Illinois Department of Public Health awarded a $2,999,999.11 contract over three years to Chartwell Rx LLC through an Invitation for Bid process posted August 28, 2026 with a response deadline of September 11, 2026, though this is a completed award rather than an open solicitation. Seminole County, Florida posted an IFB (IFB60459723LAS) on June 30, 2026 with a July 26, 2023 response deadline for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries required. The mismatch between the code's nominal scope and the actual work being solicited suggests this code may not be the primary vehicle for state and local bacitracin/polymyxin b procurement, or such procurement is not currently active in publicly posted opportunities.